Tuesday, March 26, 2019
Home Screening & Diagnostics

Screening & Diagnostics

Comparison of State-by-State Data Shows Melanoma Survival Varies Regionally

Cancer of the skin is by far the most common of all cancers and while melanoma accounts for only about 1% of all skin cancers, it causes a large majority of skin cancer deaths. According to data from the American Cancer Society, melanoma is more than 20 times more common in whites than in African Americans. Furthermore, the overall, lifetime,...

Medical Imaging Modalities for Prostate Cancer Diagnosis

Prostate cancer, which usually occurs in older men, is the second prevent type of cancer that exists. Approximately 11.2% of men will be diagnosed with prostate cancer at some point during their lifetime. Although it is usually a slowly progressing disease, prostate cancer can sometimes manifest as an aggressive cancer. The primary way to diagnose the disease is via prostate...

Study Shows that Hormone Therapy can Make Prostate Cancer Worse

Scientists at Cedars-Sinai, a non-profit, tertiary 958-bed hospital and multi-specialty academic health science center located in the Beverly Grove neighborhood of Los Angeles, California, have discovered how prostate cancer can sometimes withstand and even outwit a standard hormone therapy.  This may cause the cancer to spread. Their findings also point to a simple blood test that may help doctors predict...

Artificial Intelligence Better than Dermatologists in Diagnosing Skin Cancer

Researchers have shown for the first time that a form of artificial intelligence or machine learning known as a deep learning convolutional neural network (CNN or ConvNet), is better than experienced dermatologists at detecting skin cancer. Artificial neural network CNNs or ConvNet are a specific category of neural networks that have proven very effective in areas such as image recognition and classification. They...

Organized Prostate Cancer Screening with PSA-test does More Harm than Good

Despite a lack of evidence showing that it reduces cancer deaths, prostate cancer screening using the prostate-specific antigen or PSA-test is widely used in France. Now, according to research presented by Professor Mathieu Boniol, MD, at the 2013 European Cancer Congress (ECC2013), being held in Amsterdam, The Netherlands, September 27 - October 1, 2013, researchers have shown that men...

'Irrefutable’ Evidence Shows that Colorectal Cancer Screening Works

Screening for colorectal cancer (CRC) in European countries is highly effective in reducing mortality from the disease. A number of researchers in population based studies argue therefore, that some resources, currently being devoted to breast and prostate screening programs where the evidence of effectiveness is much less clear-cut, should be reallocated to the early detection of CRC. Data supporting...

New Test Makes Early Diagnosis of Liver Cancer a Reality

What is the effect of color? It is a powerful tool in signal action, mood control and cause physiological responses. Color has been associated with increases in blood pressure and metabolism. But what about the use of color in cancer diagnostics? Now, researchers have found a way to use colors in the detection of early liver cancer.They have developed...

High-risk Patients may Benefit from Cheap and Non-invasive Method of Diagnosing Lung Cancer

Findings presented at the European Respiratory Society(ERS) Annual Congress, being held in Barcelona, Spain (September 7 - 11, 2013), shows that collecting samples of exhaled breath from people at a high risk of lung cancer could be a cheap and non-invasive method of diagnosing the disease, according to new research.Current tests for lung cancer include blood and urine tests,...

Classification of Gastric Cancer Subtypes May Help Development of Different Treatment Approaches

According to researchers at Duke-NUS Graduate Medical School in Singapore, stomach or gastric cancer is a heterogeneous disease which falls into three broad subtypes with distinct biological properties and effects that respond differently to currently available therapies.Understanding these research findings may help improve patient care. The researchers expect that the development of a genetic test designed to classify tumors...

Blood Test Used to Detect Recurrence of Ovarian Cancer Uncovers Invasive, High-grade Disease at Curable Stage

According to researchers at The University of Texas MD Anderson Cancer Center, evaluating change over time of carbohydrate antigen 125 or CA-125, the protein long-recognized for predicting ovarian cancer recurrence, shows promise as a screening tool for early-stage disease. CA-125, a protein that is a so-called tumor marker or biomarker, is present in greater concentration in ovarian cancer cells...

right side

ads

Related articles